Publications hub
Find our publications, laboratory reports, meeting minutes and statements, and scheduling decisions.
We’re still confirming the best location for some of our content. Can't find what you’re looking for? You can also:
-
search our Resources
-
use the site search bar in the top right of this screen for more results.
Use the filters below to narrow your search.
Filter results
You can narrow down the results using the filters.
Topic
- Advisory bodies and committees (351)
- Scheduling (national classification system) (148)
- Prescription medicines (31)
- Advertising (24)
- In Vitro Diagnostic medical devices (IVDs) (24)
- Medicines safety (19)
- Therapeutic goods regulation (18)
- Medical devices safety (12)
- Manufacturing (11)
- Complementary medicines (9)
- Safety (9)
- Non-prescription medicines (8)
- Over the counter (OTC) medicines (8)
- COVID-19 vaccines (7)
- Listed medicines (7)
- Regulatory compliance (7)
- COVID-19 (6)
- Assessed listed medicines (5)
- Medicinal cannabis hub (5)
- Registered complementary medicines (5)
- Shortages (4)
- Fees and payments (3)
- Legislation (3)
- Alert/Advisory (2)
- Import and export (2)
- Artificial Intelligence (AI) (1)
- Australian Register of Therapeutic Goods (ARTG) (1)
- Biological medicines (1)
- Breast implant hub (1)
- Clinical trials (1)
- Compliance and enforcement hub (1)
- Cosmetics (1)
- Disinfectants/Sterilants (1)
- Labelling and packaging (1)
- Metal-on-metal hip replacement implants hub (1)
- Pharmacovigilance (1)
- Prescription opioids hub (1)
- Sunscreens (1)
Results for
"[search-keyword]"
Search
688 result(s) found, displaying 251 to 275
-
-
-
TGA laboratory testing reportsThe TGA has released a report on the laboratory testing of listed medicines for Aconitum alkaloid content.
-
TGA laboratory testing reportsThe TGA has released a report on the laboratory testing for toxins in medicinal cannabis products.
-
TGA laboratory testing reportsThe TGA has released a report on the laboratory testing of SAS-supplied cannabis products.
-
PublicationsThese guidelines apply to company-sponsored post-marketing surveillance studies of drug safety and toxicity
-
Meeting statementsAdvisory Committee on Medical Devices meeting statement
-
Meeting statementsA meeting statement from the second meeting of the Dental Sector Working Group is now available.
-
Meeting statementsAdvisory Committee on Vaccines meeting statement
-
Meeting statementsAdvisory Committee on Vaccines meeting statement
-
Meeting statementsAdvisory Committee on Medicines meeting statement
-
Meeting statementsAdvisory Committee on Medicines meeting statement
-
Meeting statementsAdvisory Committee on Medicines meeting statement
-
Meeting statementsAdvisory Committee on Medicines meeting statement
-
Scheduling decisions (interim)Interim decisions and invitation for further comment. Closing date: 27 August 2021
-
PublicationsAdvancing Australia's health through international regulatory engagement
-
Scheduling decisions (interim)Interim decisions and invitation for further comment. Closing date: 17 August 2021
-
Scheduling decisions (final)Notice of final decisions to amend the Poisons Standard - ACMS #32, Joint ACMS-ACCS #26, ACCS #29 (November 2020).
-
Scheduling submissionsPublic submissions made in response to the interim decisions published on 3 February 2021
-
Meeting statementsAdvisory Committee on Vaccines meeting statement
-
PublicationsThe PVIP aims to strengthen and broaden the TGA's post-market monitoring activities and protect public health
-
PublicationsThe TGA is a member of the Access Consortium along with Health Canada, Health Sciences Authority of Singapore, Swissmedic and the UK's Medicines and Healthcare products Regulatory Agency (MHRA).
-
Meeting statementsAdvisory Committee on Medical Devices meeting statement
-
Meeting statementsDetails for meeting 1 of Australian Dental Sector Working Group held on 19 April 2021.
-
Meeting statementsAdvisory Committee on Complementary Medicines (ACCM) meeting statement